Mankind Pharma shares extend gain on CCI nod for BSV acquisition
WEB1 day ago · Cheering the news, Mankind Pharma shares rose as much as 1.5% to ₹2,615, while the market capitalisation climbed to ₹1.04 lakh crore. The stock opened a tad higher at ₹2,578 after ending 2.19% up at ₹2,576.75 on October 1. The pharma stock touched its 52-week high of ₹2,780 on September 24, 2024, and a 52-week low of ₹1,685 on ...
Mankind Pharma-BSV acquisition: Major merger update from CCI …
WEB2 days ago · Mankind Pharma-BSV acquisition news: In an official statement, the CCI said the proposed transaction involves the acquisition of 100% per cent shareholding of Bharat Serums and Vaccines Limited (BSV) by Mankind Pharma Ltd (Proposed Combination). Earlier in July this year, Mankind Pharma had announced to acquire Bharat Serums and Vaccines (BSV) from Advent International for around Rs 13,630 crore.
CCI approves Mankind Pharma's purchase of Bharat Serums for …
WEB2 days ago · Mankind Pharma, which has brands including Manforce condoms and Prega News pregnancy tests, signed an agreement to acquire Bharat Serums The company, which debuted on the Indian stock exchanges in May last year, saw its market value cross $12.3 billion at the end of trading. | Photo: X@Pharma_Mankind
Proposed acquisition of Bharat Serums and Vaccines by Mankind Pharma ...
WEB3 days ago · Business News CompaniesProposed acquisition of Bharat Serums and Vaccines by Mankind Pharma for ₹13,630 crore approved by CCI Get Instant Loan up to ₹10 Lakh! Enter Mobile Number
Mankind Pharma shares in focus as company approves Rs 10,000 …
WEB3 days ago · Mankind Pharma shares are expected to remain in Focus on Tuesday as the company announced that it would raise up to Rs 10,000 crore through issuance of non-convertible debentures and commercial papers. The company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months, in a regulatory filing ...
Mankind Pharma board approves up to Rs 10,000 crore
WEB4 days ago · PTI. September 30, 2024 / 17:29 IST. The company said its board has approved to raise up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with maturities of up to 48 months ...
Mankind Pharma to raise up to ₹10,000 crore via NCDs and CPs, …
WEB4 days ago · Mankind Pharma to raise ₹100,000 crore through NCDs and CPs, with shares trading at ₹2,549.05 on NSE. SENSEX 84,299.78 -1,272.07 ... Business News Market News NSE Nifty 50 BSE Sensex
Mankind Pharma shares fall 2.5% after BSV acquisition - The Economic Times
WEBJul 26, 2024 · Shares of Mankind Pharma on Friday fell around 2.5% to day's low of Rs 2,090 on BSE after the company announced that it has signed a definitive agreement to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV) from Advent International for an enterprise value of about Rs 13,630 crore.
Mankind Pharma News - Mankind Pharma Announcement, Latest News …
WEBSep 25, 2024 · Mankind Pharma to raise Rs 10,000 crore through NCDs, CPs to fund BSV deal. | News. 30 Sep, 2024, 08:37PM IST. The company will raise up to Rs 5,000 crore through non-convertible debentures (NCDs) maturing in …
India's Mankind Pharma to buy Bharat Serums in a $1.6 billion deal
WEBJul 25, 2024 · Indian drugmaker Mankind Pharma said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ($1.63 billion), including debt.